{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:09:54Z","timestamp":1788372594406,"version":"build-2803163510"},"reference-count":14,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,2,22]],"date-time":"2010-02-22T00:00:00Z","timestamp":1266796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Cosmetic Dermatology"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> A new hyaluronic acid filler containing pre\u2010incorporated 0.3% lidocaine reduces pain and enhances patient comfort. <jats:italic>In vitro<\/jats:italic> studies confirm functional equivalence with non\u2010lidocaine\u2010containing products, but only limited data are available on the long\u2010term effects of lidocaine on filler performance in the clinical setting.<\/jats:p><jats:p><jats:bold>Aims\u2002<\/jats:bold> To investigate whether inclusion of lidocaine impacts the longevity of hyaluronic acid fillers.<\/jats:p><jats:p><jats:bold>Patients\/Methods\u2002<\/jats:bold> 60 patients with moderate\u2013severe bilateral nasolabial folds received 24\u2003mg\/mL hyaluronic acid with pre\u2010incorporated lidocaine or an equivalent product without lidocaine and were followed\u2010up for up to 76\u2003weeks.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Significantly better results were found in favor of HA gel with pre\u2010incorporated lidocaine for physician assessment of injection pain and patient pain assessment after injection (both <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001). Long\u2010term follow\u2010up of patients after almost a year showed that 91% (52\/57) of patients had no evidence of facial asymmetry, and investigators confirmed lidocaine had no effect on filler longevity. High levels of patient satisfaction and prolonged benefits due to persistence of the product were noted, with those patients needing additional treatment requiring \u2018top\u2010up\u2019 rather than full re\u2010treatment.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> The addition of 0.3% lidocaine does not affect product longevity and the small volume required for \u2018touch\u2010up\u2019 also suggests that longevity is maintained.<\/jats:p>","DOI":"10.1111\/j.1473-2165.2010.00481.x","type":"journal-article","created":{"date-parts":[[2010,2,22]],"date-time":"2010-02-22T07:33:18Z","timestamp":1266823998000},"page":"11-15","source":"Crossref","is-referenced-by-count":29,"title":["Longevity of effects of hyaluronic acid plus lidocaine facial filler"],"prefix":"10.1111","volume":"9","author":[{"given":"Herv\u00e9","family":"Raspaldo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"De Boulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip M","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,2,22]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1080\/17429590701523836"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/14764170802154607"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2007.33352.x"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2005.31213"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/14764170902833142"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.iop.0000217562.64529.ff"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.polymdegradstab.2006.11.020"},{"key":"e_1_2_8_9_2","volume-title":"Comparative Trial of a Cohesive Hyaluronic Acid Filler Formulated With and Without Lidocaine: Evaluation and Confirmation of Longevity","author":"Raspaldo H","year":"2009"},{"key":"e_1_2_8_10_2","volume-title":"Comparison of Injection Comfort and Ease with Juv\u00e9derm ULTRA 3 and Surgiderm 30 XP","author":"Levy PM","year":"2008"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.2310\/6350.2005.31253"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2008.01045.x"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.asj.2007.09.005"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/14764170701774901"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1473-2165.2008.00409.x"}],"container-title":["Journal of Cosmetic Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1473-2165.2010.00481.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1473-2165.2010.00481.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T20:08:06Z","timestamp":1698955686000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1473-2165.2010.00481.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,22]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1473-2165.2010.00481.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1473-2165.2010.00481.x","archive":["Portico"],"relation":{},"ISSN":["1473-2130","1473-2165"],"issn-type":[{"value":"1473-2130","type":"print"},{"value":"1473-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,22]]}}}